MMP9 and pulmonary fibrosis: Previous studies have indicated that metformin inhibits the activity of matrix metalloproteinases, including MMP-9, corroborating our findings that MSC administration also reduced MMP-9 levels and subsequent pulmonary fibrosis [86, 87].